Generics in North America - Market Summary, Competitive Analysis and Forecast to 2025

Generics in North America - Market Summary, Competitive Analysis and Forecast to 2025

Summary

Generics in North America industry profile provides top-line qualitative and quantitative summary information including: market size (value 2016-20, and forecast to 2025). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

  • For the purposes of this profile, a generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included.
  • The North American generics market had total revenues of $121.8bn in 2020, representing a compound annual growth rate (CAGR) of 2.3% between 2016 and 2020.
  • Market consumption volume increased with a CAGR of 0.9% between 2016 and 2020, to reach a total of 85.5% in 2020.
  • Growth in the North American generics market has been driven by the rising elderly population, due to an increase in age-associated disease, such as diabetes and cardiovascular diseases, increased access to healthcare services, high disease burden, and the launch of new products during the historic period.
Scope
  • Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the generics market in North America
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in North America
  • Leading company profiles reveal details of key generics market players’ global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the North America generics market with five year forecasts
Reasons to Buy
  • What was the size of the North America generics market by value in 2020?
  • What will be the size of the North America generics market in 2025?
  • What factors are affecting the strength of competition in the North America generics market?
  • How has the market performed over the last five years?
  • What are the main segments that make up North America's generics market?


1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Market volume
1.4. Market volume forecast
1.5. Geography segmentation
1.6. Market rivalry
1.7. Competitive Landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
3.2. Market volume
4 Market Segmentation
4.1. Geography segmentation
5 Market Outlook
5.1. Market value forecast
5.2. Market volume forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the leading players?
7.2. What are the strengths/weaknesses of the leading players?
7.3. Has there been any significant recent M&A activity?
7.4. How has the COVID-19 pandemic impacted leading players?
8 Company Profiles
8.1. Teva Pharmaceutical Industries Limited
8.2. Viatris Inc.
8.3. Pfizer Inc.
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
List of Tables
Table 1: North America generics market value: $ billion, 2016-20
Table 2: North America generics market volume: %, 2016-20
Table 3: North America generics market geography segmentation: $ billion, 2020
Table 4: North America generics market value forecast: $ billion, 2020-25
Table 5: North America generics market volume forecast: %, 2020-25
Table 6: Teva Pharmaceutical Industries Limited: key facts
Table 7: Teva Pharmaceutical Industries Limited: Annual Financial Ratios
Table 8: Teva Pharmaceutical Industries Limited: Key Employees
Table 9: Viatris Inc.: key facts
Table 10: Viatris Inc.: Annual Financial Ratios
Table 11: Viatris Inc.: Key Employees
Table 12: Pfizer Inc.: key facts
Table 13: Pfizer Inc.: Annual Financial Ratios
Table 14: Pfizer Inc.: Key Employees
Table 15: Pfizer Inc.: Key Employees Continued
Table 20: North America exchange rate, 2016-20
List of Figures
Figure 1: North America generics market value: $ billion, 2016-20
Figure 2: North America generics market volume: %, 2016-20
Figure 3: North America generics market geography segmentation: % share, by value, 2020
Figure 4: North America generics market value forecast: $ billion, 2020-25
Figure 5: North America generics market volume forecast: %, 2020-25
Figure 6: Forces driving competition in the generics market in North America, 2020
Figure 7: Drivers of buyer power in the generics market in North America, 2020
Figure 8: Drivers of supplier power in the generics market in North America, 2020
Figure 9: Factors influencing the likelihood of new entrants in the generics market in North America, 2020
Figure 10: Factors influencing the threat of substitutes in the generics market in North America, 2020
Figure 11: Drivers of degree of rivalry in the generics market in North America, 2020

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings